Lactobacillus acidophilus L-92 and Reduced Immunoglobulin E Level

Doses used in studies

mg/day: 20 (median 20, IQR 20–20) — 1 study

Safety in these studies

Overall tolerabilityReported
No abstract text explicitly mentions adverse events, side effects, or tolerability. The study only reports efficacy outcomes (SCORAD, TARC, total IgE) without any mention of safety findings.
from: Additive effect of Lactobacillus acidophilus L-92 on children with atopic dermatitis conco

1 of 1 paper

Additive effect of Lactobacillus acidophilus L-92 on children with atopic dermatitis concomitant with food allergy

2019-04
RCT · n = 59
Asia Pacific Allergy 9(2)
- Joan Nakata
- Tatsuhiko Hirota
- Harue Umemura
- T. Nakagawa
- N. Kando
- M. Futamura
- Yasunori Nakamura
- Komei Ito

PubMed: 31089460
DOI: 10.5415/apallergy.2019.9.e18

7 Insights on

Reduced Immunoglobulin E Level

High evidence
Rigorous Journal
Clinical

Significant decreases in thymus and activation-regulated chemokine (TARC) and total IgE were also detected 24 weeks after intake in the L-92 group compared with the placebo group.

Effect: Beneficial
Effect size: Moderate
Significant: Yes
Dose: 20 mg L-92/day